Next Score View the next score

    Ideas | Catharine Wang

    The dodgy world of do-it-yourself genetics

    Adobe Stock

    AS PERSONAL DNA TESTING becomes routine, some ethicists fear violations of Americans’ privacy. But the greatest risk may lie in what people know — or think they know — about themselves.

    A few years back, I learned of a patient who had her DNA tested by one company and then interpreted by another. She sought help when data from the third-party company suggested she was at increased genetic risk for breast cancer. Concern over what had been identified in the interpretation report ultimately led this patient to see a genetic counselor — a trained professional who can advise on the genetic risks for various diseases. The counselor eventually determined the result was nothing to worry about.

    For me, this “false positive” case raised red flags about a sometimes dodgy do-it-youself world of genetics. It may provide access to personal genetic information for the masses, but in many cases, individuals aren’t fully aware of all they may find out, or how their data may be used.


    Because of aggressive marketing and the popularization of “gifting” recreational ancestry tests, more consumers than ever are sending samples to companies such as AncestryDNA or 23and Me . The recent arrest of a suspect in the Golden State Killer case has heightened concerns about privacy and ethics; law enforcement used a third-party DNA interpretation company to identify close relatives and zero in on a likely culprit.

    Get Today in Opinion in your inbox:
    Globe Opinion's must-reads, delivered to you every Sunday-Friday.
    Thank you for signing up! Sign up for more newsletters here

    The company, GEDmatch, is well-known among genetic genealogy enthusiasts. When consumers want to learn more about their relatives than previously revealed by commercial testing companies, they can seek out third-party companies like this one for further interpretation of their DNA results.

    But, in addition to clues about where your ancestors were from, DNA holds information about your own medical risks. Here, at the intersection of recreational genetic genealogy and personal health information, is where direct-to-consumer companies are generating some unintended spillover effects that consumers may not be prepared for.

    I approach this area from the medical side. My own work focuses on how people use genomic information for personal health benefits. In particular, I’ve looked at when and how people decide to undergo genetic testing, and how they understand and cope with their results.

    When I interviewed the patient who thought she had an elevated risk of breast cancer, it turned out she’d stumbled into the area of genetic testing for health risks while exploring her interest in genealogy. While watching scholar Henry Louis Gates’s PBS show “Finding Your Roots,” she saw an ad for one of the commercial direct-to-consumer companies that offered ancestry testing.


    Once the patient learned her ancestry results, she also realized that an entire world had opened up in terms of other possible nuggets of information she could discover from her “raw” DNA data. So she purchased access to a third-party health app to interpret her raw DNA. It was these results — provided without consultation with a medical professional — which then led her to clinic.

    Currently, there are many of these third-party apps or online services available to consumers. They’re not regulated by the Food and Drug Administration since, as argued by the companies behind them, they just serve as a “bridge to the literature” and only provide access to the scientific evidence base.

    My colleagues and I surveyed customers of these third-party companies to learn more about their motives for exploring the raw DNA data they’d received from commercial testing companies. Approximately two-thirds of consumers we surveyed were highly motivated to explore raw DNA for ancestral details. Forty percent were interested in both ancestry and health information.

    Sixty-two percent of our respondents used GEDmatch, highlighting the extent to which DNA data that are heavily protected by companies such as AncestryDNA and 23andMe are unguarded by consumers themselves. Many choose to freely upload that data in hopes of finding other relatives. Notably, almost three-quarters of consumers reported using more than one third-party company to interpret their DNA.

    Some might argue these tools provide a beneficial service for consumers, particularly when it comes to learning more about their health risks. In cases where genetic risks are determined via clinically validated tests, it can be empowering. Angelina Jolie is the perfect example.


    Yet, the validity of genetic tests to which consumers have direct access remains questionable. In fact, a recent article by scientists at one of the clinical testing labs that medical providers rely on reported that approximately 40 percent of results reported from raw DNA interpretation were incorrect. Thus, 4 out of 10 people are told they have a greater risk for a disease, when they do not. That’s an exceedingly high number of individuals to stress out with a false positive result.

    My ongoing work has found that “worry” is the primary driver for patients to seek out medical assistance in raw DNA interpretation. As such, this false positive rate has a notable downstream burden on the healthcare system.

    Social media sites like Reddit are filled with examples of consumers who are confused about how to interpret the reports generated from some of these third-party companies, which vary greatly in clarity and quality. Or, they have learned from a report they might have a BRCA variant that might confer high risk for breast and ovarian cancer, and ask other site users for help in understanding whether their result is real.

    It doesn’t have to be this way; there are genetic counselors who specialize in interpreting these kinds of results and helping patients figure out what to do.

    Genetic counselors, meanwhile, are frustrated. The message from commercial testing companies has led to unrealistic expectations from consumers about what they can learn about themselves. It’s challenging for counselors to correct misconceptions, especially when they are met with resistance from patients.

    If 2017 was the year commercial direct-to-consumer testing exploded, 2018 may be the year users rethink the value of this gift — or at least how to use it. Once the genie is out of the bottle, it isn’t going back.

    Catharine Wang is an associate professor of community health sciences at Boston University. This piece was adapted from a post at The Conversation.